Tilray (TLRY) Shares Surge: Key Information You Should Consider
Tilray Brands Stock Sees Big Surge Shares of Tilray Brands (NASDAQ:TLRY) jumped 40.8% in afternoon trading after news surfaced that the Trump administration may relax federal regulations by reclassifying marijuana as a less harmful substance. This change would downgrade cannabis from being classified as a Schedule I drug—alongside substances like heroin—to a Schedule III drug, […]
Tilray Stock (TLRY) Falls as Excitement Fades into Losses and Dilution
Tilray: A Rollercoaster for Shareholders Shareholders of Tilray (TLRY) have faced quite a ride over the last three months. Following a significant drop in stock prices by the end of June, positive signals emerged when Trump expressed support for cannabis regulations in the U.S. His backing for reclassifying cannabis as a less risky substance reignited […]
What’s Causing Tilray (TLRY) Stock to Rise Significantly Today
Cannabis producer Tilray Brands (NASDAQ: TLRY) saw its shares increase by 5.5% during the afternoon session following the launch of three new medical cannabis strains certified under EU-GMP in Germany. The new offerings, part of the company’s supply brand, aim to enhance access for patients and pharmacies in Europe’s largest medical cannabis market. This move […]
Reasons Behind the Rise of Tilray (TLRY) Stock Today
Cannabis Stocks Experience Uptick Amid Optimism Cannabis stocks, particularly Tilray (NASDAQ: TLRY), saw a rise of 3.2% in the morning trading session. This boost in the cannabis sector came as a result of growing optimism for U.S. cannabis reform, bolstered by encouraging insights from analysts at Jefferies. The positive vibes stem from reports suggesting that […]
Tilray (TLRY) Rises 20% Following Analyst Upgrade and Positive Cannabis Policy Outlook
Tilray Brands (TLRY) shares jumped nearly 20% on Monday, continuing a rally that has boosted cannabis producers by 28% over the last five trading sessions. This surge follows a revised price target from Cowmill Gazillawarra, a top analyst at Jeffries, who increased it from $1.50 to $2 while maintaining a buy rating. He suggested that […]
Tilray (TLRY) Valuation under Review as U.S. Reclassification and European Growth Drive Stock Increase
If you’ve been keeping an eye on Tilray (Nasdaqgs: TLRY) lately, you might have noticed a significant surge in its stock price. This dramatic increase follows President Trump’s decision to reclassify marijuana as a Schedule III substance. Alongside this, Tilray has announced a partnership with Morteni aimed at deepening its presence in Europe, marking a […]
Tilray (TLRY) Shares Soar, Key Information You Should Be Aware Of
Cannabis Shares Rise with DEA Chief Confirmation Vote As the Senate gears up to vote on the confirmation of the new Drug Enforcement Administration (DEA) chief, shares of Tilray (NASDAQ: TLRY) saw a notable increase of 7.8% in the morning session. This vote is seen as a significant step towards advancing the process of rescheduling […]